Dominic Reynolds

Company: Remix Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Evaluating High-Value Direct RNA & Protein/RNA Complex Target Traits for Ensuring Efficient Binding & Therapeutic Effect for Accelerating Relevant Drug Discovery 12:10 pm

What are the key characteristics which validated RNA and RNA/protein targets share? How to conduct high resolution characterization of RNA targets including the different proteins and binding compounds present in the body How to determine RNA sub-targets which can be both bound by small molecule targets and cause therapeutic effectsRead more

day: Day One

Leveraging Strategies to Drug RNA-Protein Complexes with Small Molecule 4:00 pm

Identifying disease relevant RNA-protein targets for previously intractable diseases Developing screening assay strategies for the discovery of novel small molecule splicing modulators Optimizing toward more potent and efficacious small molecule therapeutics: moving from early discovery to preclinical development for more streamlined translation towards the clinicRead more

day: Day One